AB SCIEX and the Samuel Lunenfeld Research Institute to Collaborate in Disease Research Project

Organizations to Focus on Advancing Protein Research Through Emerging Mass
Spectrometry Technology
FOSTER CITY, Calif. & TORONTO--(Business Wire)--
AB SCIEX, a global leader in life science analytical technologies, today
announced that it is collaborating with the Samuel Lunenfeld Research Institute
of Mount Sinai Hospital, one of the world`s leading centers for biomedical
research, to improve disease studies. The project is focused on better
understanding cancer, diabetes and heart disease by advancing the study of
proteins through the use of an emerging mass spectrometry platform currently
under development by AB SCIEX.

Leading researcher Tony Pawson, Ph.D., a Kyoto Prize-winning scientist, and his
team at the Lunenfeld are focusing their biomedical studies on analyzing complex
protein interactions and modifications in the pathways and processes of
communication between cells. The Lunenfeld is at the forefront of using mass
spectrometry technology to apply protein research to enhance the field of cell
biology and provide new insights into human diseases.

Through this collaboration, Lunenfeld researchers are using the life science
industry`s first mass spectrometry system that combines qualitative and
quantitative analysis at high resolution, high speed and high sensitivity with
accurate mass. The result will be new workflows and applications that will be
made available to the global life science community when AB SCIEX launches the
new platform later this year. These workflows and applications will help expand
the use of mass spectrometry across the life sciences.

Quotes

Tony Pawson, Ph.D., Distinguished Investigator, Samuel Lunenfeld Research
Institute

"Mass spectrometry has incredible power to support human health by unraveling
mysteries of the basic mechanisms of diseases. The new AB SCIEX accurate-mass
technology is a significant leap forward in mass spectrometry tools for
biomedical analysis, enabling us to better understand highly complex medical
conditions and improve the quality of information emerging in the field of cell
biology. This could lead to better ways to treat diseases in the future."

Dave Hicks, Vice President and General Manager of Pharmaceuticals and
Proteomics, AB SCIEX

"Scientists around the world continue to adopt mass spectrometry to solve some
of science`s biggest challenges. This collaboration between AB SCIEX and the
Samuel Lunenfeld Research Institute is a great example of the power of this
technology to understand more about the complexities of proteins and apply this
knowledge to disease research. Through the development of workflows and
applications, we will be able to deliver more effective ways of working that
will be available on the industry`s most unique mass spectrometry platform."

Media Resources

Protein research primer

Cell signaling overview

AB SCIEX technology portfolio

About the Samuel Lunenfeld Research Institute of Mount Sinai Hospital

The Samuel Lunenfeld Research Institute of Mount Sinai Hospital, a University of
Toronto affiliated research centre established in 1985, is one of the world's
premier centres in biomedical research. Thirty-four principal investigators lead
research in diabetes, cancer biology, epidemiology, stem cell research, women's
and infants' health, neurobiology and systems biology. For more information on
the Samuel Lunenfeld Research Institute, please visit www.lunenfeld.ca.

About AB SCIEX

AB SCIEX is a global leader in the development of life science analytical
technologies that help answer complex scientific challenges. The company
provides mass spectrometry and liquid chromatography systems, software and
services that are used to discover new drugs, advance medical science and
protect the food supply and the environment. The company has a more than 20-year
history of innovation and market leadership as the former Applied Biosystems/MDS
Analytical Technologies joint venture. For more information about AB SCIEX, go
to www.absciex.com.

Follow AB SCIEX on Twitter @ABSCIEX and on Facebook.

Social Media Tags

AB SCIEX, mass spectrometry, cell biology, protein research,
phosphorylation,qualitative, quantitative analysis, analytical science,
biomedical, cancer, diabetes, diseases research, proteomics

For Research Use Only. The trademarks mentioned herein are the property of AB
Sciex Pte. Ltd. or their respective owners. AB SCIEX is being used under
license.

© 2010 AB SCIEX.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6260265&lang=en

Media Contact
AB SCIEX
Anthony Petrucci, 508-383-7961
Senior Manager, Corporate Communications
anthony.petrucci@absciex.com

Copyright Business Wire 2010